报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.66% | -7.04% | 269.23% | 97/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | -0.39% | -129.41% | -214.71% | 106/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.34% | -17.07% | 118.78% | 95/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | -1.81% | -503.33% | -354.93% | 104/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 0.71% | -69.92% | 517.65% | 103/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | -0.17% | -116.5% | -141.46% | 110/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 0.41% | -76.7% | 236.67% | 100/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | -0.3% | -101.45% | -112.71% | 108/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 2.36% | -88.95% | 129.13% | 100/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 1.03% | -92.43% | -41.48% | 105/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.76% | 2% | -91.49% | 72/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 20.69% | 246.57% | -3.14% | 37/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 21.36% | 2% | 57.06% | 20/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 13.6% | 53.5% | 127.81% | 30/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2020-12-31 | 5.97% | -48.36% | -32.62% | 102/129 | 25.82% | 热景生物 | 57.63% | 行业排名> |
2020-06-30 | 8.86% | 2% | -23.36% | 48/129 | 15.16% | 中红医疗 | 168% | 行业排名> |
2019-12-31 | 11.56% | 42.54% | 42.54% | 70/129 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
2018-12-31 | 8.11% | 11.71% | 11.71% | 78/129 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
2017-12-31 | 7.26% | 2% | 2% | 72/129 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |